Today's Information

Provided by: MAXIGEN BIOTECH INC.
SEQ_NO 1 Date of announcement 2022/07/07 Time of announcement 16:45:06
Subject 
 Monthly revenue report, June 2022
Date of events 2022/07/07 To which item it meets paragraph 51
Statement 
1.Date of occurrence of the event:2022/07/07
2.Company name:Maxigen Biotech Inc
3.Relationship to the Company (please enter "head office" or
  "subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:N/A
6.Countermeasures:N/A
7.Any other matters that need to be specified:
Maxigen Biotech Inc. (TWSE: 1783) today announced its net revenues
for June 2022.
On a consolidated basis, revenues for June 2022 were
approximately NT$ 62.372 million, an increase of 29.83 percent
over the same period in 2021.
Revenues for January through June 2022 totaled
NT$ 277.516 million, an increase of 19.58 percent compared to
the NT$ 232.083 million for the same period in 2021.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Maxigen Biotech Inc. published this content on 07 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 July 2022 11:23:01 UTC.